{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:28:41Z","timestamp":1793021321435,"version":"4.5.0"},"reference-count":233,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016658","name":"Plan Nacional sobre Drogas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018685","name":"Govern de les Illes Balears Direccio General de Politica Universitaria i Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018685","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.phrs.2024.107085","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T01:37:45Z","timestamp":1706837865000},"page":"107085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Novel rapid treatment options for adolescent depression"],"prefix":"10.1016","volume":"201","author":[{"given":"Sandra","family":"Ledesma-Corvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Jornet-Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"G\u00e1lvez-Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107085_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmj.330.7486.301","article-title":"Adolescent development","volume":"330","author":"Christie","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2024.107085_bib2","unstructured":"E.P. Backes, R.J. Bonnie (editors), Adolescent development, The promise of adolescence: realizing opportunity for all youth, National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Division of Behavioral and Social Sciences and Education; Board on Children, Youth, and Families; Committee on the Neurobiological and Socio-behavioral Science of Adolescent Development and Its Applications, Washington (DC): National Academies Press (US); 2019 May 16."},{"key":"10.1016\/j.phrs.2024.107085_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/apa.13299","article-title":"The neuroscience and context of adolescent depression","volume":"105","author":"Henje Blom","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.phrs.2024.107085_bib4","unstructured":"WHO,2021. Depression. Geneva, Switzerland: World Health Organization. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression\u3009 (last accessed 19 July, 2023)."},{"key":"10.1016\/j.phrs.2024.107085_bib5","unstructured":"WHO,2021. Suicide. Geneva, Switzerland: World Health Organization. Available from \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/suicide\u3009 (last accessed 19 July, 2023)."},{"issue":"2022","key":"10.1016\/j.phrs.2024.107085_bib6","first-page":"137","article-title":"Mental disorders collaborators, global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"9","author":"GBD","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib7","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1469-7610.2006.01682.x","article-title":"Is there an epidemic of child or adolescent depression","volume":"47","author":"Costello","year":"2006","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107085_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jadohealth.2017.12.019","article-title":"Gendered mechanisms underlie the relation between pubertal timing and adult depressive symptoms","volume":"62","author":"Beltz","year":"2018","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.phrs.2024.107085_bib10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/s41386-019-0524-3","article-title":"Analysis of sex differences in pre-clinical and clinical data sets","volume":"44","author":"Beltz","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0006-3223(02)01372-0","article-title":"Development and natural history of mood disorders","volume":"52","author":"Costello","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib12","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1017\/S0033291709005364","article-title":"Does major depressive disorder change with age","volume":"39","author":"Coryell","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.phrs.2024.107085_bib13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jamapsychiatry.2020.0158","article-title":"The age of depression and its treatments","volume":"77","author":"Hofmann","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-0327(02)00426-3","article-title":"Epidemiology of women and depression","volume":"74","author":"Kessler","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2004.09.008","article-title":"Gender differences in depression: findings from the STAR*D study","volume":"87","author":"Marcus","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pneurobio.2019.01.006","article-title":"Sex differences in depression: insights from clinical and preclinical studies","volume":"176","author":"Eid","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107085_bib17","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/aje\/kwab002","article-title":"Is the US gender gap in depression changing over time? A meta-regression","volume":"190","author":"Platt","year":"2021","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2024.107085_bib18","article-title":"Annual research review: sex, gender, and internalizing conditions among adolescents in the 21st century - trends, causes, consequences","author":"Keyes","year":"2023","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.psc.2023.02.007","article-title":"Special populations: treatment-resistant depression in children and adolescents","volume":"46","author":"Ayvaci","year":"2023","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.phrs.2024.107085_bib20","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jadohealth.2022.08.008","article-title":"Twenty-five years of national-level research on adolescent and young adult mental health in the United States","volume":"71","author":"Crosnoe","year":"2022","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.phrs.2024.107085_bib21","first-page":"19","article-title":"Latent classes of symptoms related to clinically depressed mood in adolescents","volume":"2","author":"Blom","year":"2014","journal-title":"Scand. J. Child Adolesc. Psychiatr. Psychol."},{"key":"10.1016\/j.phrs.2024.107085_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/apa.13299","article-title":"The neuroscience and context of adolescent depression","volume":"105","author":"Henje Blom","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.phrs.2024.107085_bib23","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jadohealth.2012.05.006","article-title":"Adolescent neurodevelopment","volume":"52","author":"Spear","year":"2013","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.phrs.2024.107085_bib24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuint.2007.06.025","article-title":"Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs","volume":"51","author":"Bylund","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2024.107085_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.euroneuro.2020.10.008","article-title":"Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: Regulation of the early stages of hippocampal neurogenesis","volume":"41","author":"Garc\u00eda-Cabrerizo","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib26","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00213-020-05481-4","article-title":"Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol","volume":"237","author":"Bis-Humbert","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174465","article-title":"Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: comparison with adult rats","volume":"910","author":"Bis-Humbert","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107085_bib28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107085_bib29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archpsyc.64.10.1132","article-title":"The treatment for adolescents with depression study (TADS): long-term effectiveness and safety outcomes","volume":"64","author":"March","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2024.107085_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis","volume":"7","author":"Zhou","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jcpp.13202","article-title":"Annual research review: defining and treating pediatric treatment-resistant depression","volume":"61","author":"Dwyer","year":"2020","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","article-title":"Sex differences in antidepressant efficacy","volume":"44","author":"LeGates","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040949","article-title":"Decoding the mechanism of action of rapid-acting antidepressant treatment strategies: Does gender matter?","volume":"20","author":"Herzog","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s44220-023-00076-2","article-title":"Integrating sex and gender in mental health research: enhanced funding for better treatments","volume":"1","author":"Dalla","year":"2023","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.phrs.2024.107085_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/17425255.2011.544250","article-title":"Sex differences in pharmacokinetics of antidepressants","volume":"7","author":"Kokras","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.phrs.2024.107085_bib37","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1111\/bph.14761","article-title":"Sex: a change in our guidelines to authors to ensure that this is no longer an ignored experimental variable","volume":"176","author":"Docherty","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107085_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13749","article-title":"Analysis of female enrollment and participant sex by burden of disease in US clinical trials between 2000 and 2020","volume":"4","author":"Steinberg","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.phrs.2024.107085_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/d41573-021-00115-6","article-title":"Implications of sex-related differences in central nervous system disorders for drug research and development","volume":"20","author":"Butlen-Ducuing","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2024.107085_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","article-title":"Novel and emerging treatments for major depression","volume":"401","author":"Marwaha","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107085_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1308.002","article-title":"Adolescent brain development and animal models","volume":"1021","author":"Spear","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2024.107085_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00008877-200409000-00005","article-title":"Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model","volume":"15","author":"Adriani","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1096\/fj.201600781r","article-title":"Considering sex as a biological variable in preclinical research","volume":"31","author":"Miller","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2024.107085_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s44220-023-00083-3","article-title":"Sex as a biological variable in stress and mood disorder research","volume":"1","author":"Hodes","year":"2023","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.phrs.2024.107085_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresbull.2022.07.009","article-title":"Neuromodulation and hippocampal neurogenesis in depression: a scoping review","volume":"188","author":"Flores","year":"2022","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.phrs.2024.107085_bib47","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1176\/appi.ajp.2021.21101034","article-title":"Neuromodulation strategies for the treatment of depression","volume":"178","author":"Conroy","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1192\/bjp.164.1.106","article-title":"Is there a delay in the onset of the antidepressant effect of electroconvulsive therapy","volume":"164","author":"Rodger","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107085_bib50","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.biopsych.2013.01.034","article-title":"Rapid effects of deep brain stimulation for treatment-resistant major depression","volume":"73","author":"Schlaepfer","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/ajp.94.6S.172","article-title":"Experimental researches on epileptic attacks induced by electric current","volume":"94","author":"Bini","year":"1938","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib52","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2024.107085_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fpsyg.2020.00080","article-title":"Effects of electroconvulsive therapy on depression and its potential mechanism","volume":"11","author":"Li","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.phrs.2024.107085_bib54","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3892\/etm.2021.10716","article-title":"Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression","volume":"22","author":"Trifu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.phrs.2024.107085_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/09540261.2017.1309362","article-title":"Key updates in the clinical application of electroconvulsive therapy","volume":"29","author":"Weiner","year":"2017","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib56","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT)","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.phrs.2024.107085_bib57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamapsychiatry.2023.0562","article-title":"Ketamine vs electroconvulsive therapy for major depressive episode: a systematic review and meta-analysis","volume":"80","author":"Menon","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib58","article-title":"Effectiveness of electroconvulsive therapy for preventing relapse and recurrence of depression in adults with major depressive disorder: an updated meta-analysis of randomized clinical trials","volume":"15","author":"Dar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.phrs.2024.107085_bib59","article-title":"Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: protocol for a systematic review and network meta-analysis","volume":"12","author":"Nikolin","year":"2022","journal-title":"B. M. J. Open"},{"key":"10.1016\/j.phrs.2024.107085_bib60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/ACO.0000000000001279","article-title":"Electroconvulsive therapy: recent advances and anesthetic considerations","volume":"36","author":"Ninke","year":"2023","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"10.1016\/j.phrs.2024.107085_bib61","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/diagnostics13091585","article-title":"Clinical improvement in depression and cognitive deficit following electroconvulsive therapy","volume":"13","author":"Ahmad Hariza","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.phrs.2024.107085_bib62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00124509-200106000-00005","article-title":"Electroconvulsive therapy for minors: Experiences and attitudes of child psychiatrists and psychologists","volume":"17","author":"Ghaziuddin","year":"2001","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/YCT.0000000000000489","article-title":"Experience, knowledge, and attitudes of child and adolescent psychiatrists in Belgium toward pediatric electroconvulsive therapy","volume":"34","author":"De Meulenaere","year":"2018","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib64","article-title":"Systematic review: electroconvulsive therapy for treatment-resistant mood disorders in children and adolescents","author":"Castaneda-Ramirez","year":"2022","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007870050109","article-title":"Electroconvulsive therapy in adolescence","volume":"9","author":"Cohen","year":"2000","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chc.2018.07.001","article-title":"Pathway to electroconvulsive treatment for minors, child","volume":"28","author":"Freeman","year":"2019","journal-title":"Adolesc. Psychiatr. Clin. N Am."},{"key":"10.1016\/j.phrs.2024.107085_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/YCT.0000000000000602","article-title":"Efficacy and safety of electroconvulsive therapy in adolescents: A retrospective chart review study from Turkey","volume":"36","author":"Karaya\u011fmurlu","year":"2020","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib68","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/01.chi.0000142280.87429.68","article-title":"Practice parameter for use of electroconvulsive therapy with adolescents","volume":"43","author":"Ghaziuddin","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib69","doi-asserted-by":"crossref","unstructured":"N. Ghaziuddin, G. Walter, Electroconvulsive therapy in children and adolescents, 2014. https:\/\/doi.org\/10.1093\/med\/9780199937899.001.0001.","DOI":"10.1093\/med\/9780199937899.001.0001"},{"key":"10.1016\/j.phrs.2024.107085_bib70","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/YCT.0000000000000761","article-title":"Electroconvulsive therapy in children and adolescents: a systematic review of current literature and guidelines","volume":"37","author":"D\u00f8ssing","year":"2021","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2795","article-title":"A retrospective case series of electroconvulsive therapy in the management of depression and suicidal symptoms in adolescents","volume":"12","author":"Chen","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.phrs.2024.107085_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2023.02.027","article-title":"Electroconvulsive therapy-induced neuroimaging alterations measured by cerebral blood flow in adolescents with major depressive disorder","volume":"327","author":"Yu","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib73","article-title":"Electroconvulsive therapy in children and adolescents in Europe - a systematic review of the literature complemented by expert information and guideline recommendations","author":"Licht","year":"2023","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/YCT.0b013e31827e0d22","article-title":"Electroconvulsive therapy in adolescents: a retrospective study from north India","volume":"29","author":"Grover","year":"2013","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib75","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCT.0000000000000236","article-title":"Use of electroconvulsive therapy in adolescents with treatment-resistant depressive disorders: a case series","volume":"31","author":"Zhand","year":"2015","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib76","doi-asserted-by":"crossref","first-page":"19m13164","DOI":"10.4088\/JCP.19m13164","article-title":"Outcomes of youth treated with electroconvulsive therapy: a retrospective cohort study","volume":"82","author":"Pierson","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib77","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/YCT.0b013e3181fb3924","article-title":"Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics","volume":"26","author":"Consoli","year":"2010","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/cap.2019.0054","article-title":"Electroconvulsive therapy for the treatment of severe mood disorders during adolescence: a retrospective chart review","volume":"30","author":"Ghaziuddin","year":"2020","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/YCT.0000000000000906","article-title":"Suicidal ideation and electroconvulsive therapy: outcomes in adolescents with major depressive disorder","volume":"39","author":"Cai","year":"2023","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib80","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.157.3.460","article-title":"Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder","volume":"157","author":"Cohen","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/cap.2000.10.269","article-title":"Cognitive side effects of electroconvulsive therapy in adolescents","volume":"10","author":"Ghaziuddin","year":"2000","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2023.06.052","article-title":"Response rate and safety of antidepressants combined with electroconvulsive therapy in adolescent depression: real-world clinical application","volume":"339","author":"Li","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib83","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2023.11.009","article-title":"Warning: High incidence rate of cognitive impairment from electroconvulsive therapy with adolescents","volume":"346","author":"Read","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/acps.12721","article-title":"The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis","volume":"135","author":"T\u00f8rring","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.phrs.2024.107085_bib85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/pan.13115","article-title":"Anesthetic considerations for pediatric electroconvulsive therapy","volume":"27","author":"Franklin","year":"2017","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.phrs.2024.107085_bib86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1213\/ANE.0000000000004337","article-title":"Anesthetic management during electroconvulsive therapy in children: a systematic review of the available literature","volume":"130","author":"Stein","year":"2020","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.phrs.2024.107085_bib87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/YCT.0000000000000723","article-title":"Current practices of electroconvulsive therapy in mental disorders: a systematic review and meta-analysis of short and long-term cognitive effects","volume":"37","author":"Landry","year":"2021","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.yct.0000263254.21668.f0","article-title":"Seizure length in electroconvulsive therapy as a function of age, sex, and treatment number","volume":"23","author":"Rasimas","year":"2007","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/YCT.0b013e3181e48165","article-title":"Electroconvulsive therapy stimulus parameters: rethinking dosage","volume":"26","author":"Peterchev","year":"2010","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib90","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/YCT.0000000000000508","article-title":"Pertinence of titration and age-based dosing methods for electroconvulsive therapy: an international retrospective multicenter study","volume":"34","author":"Lemasson","year":"2018","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/YCT.0000000000000671","article-title":"Electroconvulsive therapy in depression: improvement in quality of life depending on age and sex","volume":"36","author":"G\u00fcney","year":"2020","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2022.12.144","article-title":"Sex-specifics of ECT outcome","volume":"326","author":"Blanken","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib93","first-page":"143","article-title":"J. Pifarr\u00e9 Paredero, et al., electroconvulsive therapy clinical database: Influence of age and gender on the electrical charge, Rev. Psiquiatr","volume":"10","author":"Salvador S\u00e1nchez","year":"2017","journal-title":"Salud Ment."},{"key":"10.1016\/j.phrs.2024.107085_bib94","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.brs.2018.08.001","article-title":"Short- and long-term efficacy of electroconvulsive stimulation in animal models of depression: the essential role of neuronal survival","volume":"11","author":"Jonckheere","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.phrs.2024.107085_bib95","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-016-4342-6","article-title":"Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD\/FADD ratio after chronic desipramine and fluoxetine administration","volume":"233","author":"Garc\u00eda-Fuster","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13293-023-00552-5","article-title":"Comparing the antidepressant-like effects of electroconvulsive seizures in adolescent and adult female rats: an intensity dose-response study","volume":"14","author":"Ledesma-Corvi","year":"2023","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.phrs.2024.107085_bib97","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ijnp\/pyad047","article-title":"Aromatase inhibition and electroconvulsive seizures in adolescent rats: antidepressant and long-term cognitive sex differences","volume":"26","author":"Ledesma-Corvi","year":"2023","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib98","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.lfs.2007.01.032","article-title":"Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test","volume":"80","author":"Li","year":"2007","journal-title":"Life. Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib99","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00210-016-1334-3","article-title":"Effect of sildenafil on the activity of some antidepressant drugs and electroconvulsive shock treatment in the forced swim test in mice","volume":"390","author":"Soca\u0142a","year":"2017","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.phrs.2024.107085_bib100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.psychres.2014.12.068","article-title":"Behavioral and molecular responses to electroconvulsive shock differ between genetic and environmental rat models of depression","volume":"226","author":"Luo","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.phrs.2024.107085_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1195","article-title":"Electroconvulsive treatment prevents chronic restraint stress-induced atrophy of the hippocampal formation: a stereological study","volume":"9","author":"Alemu","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.phrs.2024.107085_bib102","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.brs.2021.05.016","article-title":"Changes in seizure duration during acute course electroconvulsive therapy","volume":"14","author":"Luccarelli","year":"2021","journal-title":"Brain Stimul."},{"key":"10.1016\/j.phrs.2024.107085_bib103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jad.2006.04.029","article-title":"Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine","volume":"95","author":"Berlanga","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.phrs.2024.107085_bib104","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pbb.2007.09.003","article-title":"Estrogens participate in the antidepressant-like effect of desipramine and fluoxetine in male rats","volume":"88","author":"Mart\u00ednez-Mota","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2024.107085_bib105","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40262-014-0145-2","article-title":"Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives","volume":"53","author":"Damoiseaux","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.phrs.2024.107085_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173998","article-title":"Antidepressants' effects on testosterone and estrogens: what do we know?","volume":"899","author":"Pavlidi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.physiol.64.081601.142703","article-title":"Aromatase -- a brief overview","volume":"64","author":"Simpson","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2024.107085_bib108","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1017\/S1461145714000212","article-title":"Acute but not sustained aromatase inhibition displays antidepressant properties","volume":"17","author":"Kokras","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib109","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13293-023-00560-5","article-title":"Aromatase inhibition and ketamine in rats: sex\u2011differences in antidepressant\u2011like efficacy","volume":"14","author":"Ledesma-Corvi","year":"2023","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.phrs.2024.107085_bib110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1176\/ajp.151.7.957","article-title":"Does ECT alter brain structure?","volume":"151","author":"Devanand","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib111","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1059-1311(97)80034-9","article-title":"Seizures, memory and synaptic plasticity","volume":"6","author":"Reid","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.phrs.2024.107085_bib112","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jpsychires.2007.08.009","article-title":"Possible glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: experimental evidence for involvement of COX-2, and review of literature","volume":"42","author":"Andrade","year":"2008","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.phrs.2024.107085_bib113","article-title":"How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both","author":"Deng","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib114","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.psc.2018.04.008","article-title":"Therapeutic applications of invasive neuromodulation in children and adolescents","volume":"41","author":"Doruk Camsari","year":"2018","journal-title":"Psychiatr. Clin. North. Am."},{"key":"10.1016\/j.phrs.2024.107085_bib115","unstructured":"FDA permits marketing of deep brain stimulation for treatment of Parkinson's disease. \u3008https:\/\/www.ninds.nih.gov\/about-ninds\/impact\/ninds-contributions-approved-therapies\/deep-brain-stimulation-dbs-treatment-parkinsons-disease-and-other-movement-disorders\u3009. Last reviewed on March 13, 2023. Accessed July 25, 2023."},{"key":"10.1016\/j.phrs.2024.107085_bib116","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s13311-022-01270-3","article-title":"Deep brain stimulation for depression","volume":"19","author":"Figee","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2024.107085_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-023-02181-1","article-title":"Functional brain network features specify DBS outcome for patients with treatment resistant depression","author":"Ghaderi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib118","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.3390\/jcm9092796","article-title":"Deep brain stimulation is effective for treatment-resistant depression: a meta-analysis and meta-regression","volume":"9","author":"Hitti","year":"2020","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.phrs.2024.107085_bib119","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/da.22746","article-title":"A systematic review and meta-analysis of deep brain stimulation for depression","volume":"35","author":"Kisely","year":"2018","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.phrs.2024.107085_bib120","doi-asserted-by":"crossref","first-page":"1125074","DOI":"10.3389\/fnhum.2023.1125074","article-title":"Neuromodulation for treatment-resistant depression: functional network targets contributing to antidepressive outcomes","volume":"17","author":"Idlett-Ali","year":"2023","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.phrs.2024.107085_bib121","unstructured":"U.S. Food and Drug Administration (2011) Guidance for Industry and Food and Drug Administration Staff\u2013Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation (rTMS) Systems. http:\/\/www.fda.gov. Published July 2011. Accessed July 25, 2023."},{"key":"10.1016\/j.phrs.2024.107085_bib122","unstructured":"FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive-compulsive disorder. \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-permits-marketing-transcranial-magnetic-stimulation-treatment-obsessive-compulsive-disorder\u3009. Published August 2018. Accessed July 25, 2023."},{"key":"10.1016\/j.phrs.2024.107085_bib123","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.psychres.2010.03.004","article-title":"rTMS for adolescents: safety and efficacy considerations","volume":"177","author":"D'Agati","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.phrs.2024.107085_bib124","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chc.2018.07.003","article-title":"Transcranial magnetic stimulation for adolescent depression","volume":"28","author":"Croarkin","year":"2019","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.phrs.2024.107085_bib125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YCT.0b013e318238f01a","article-title":"Long-term follow-up of adolescents with resistant depression treated with repetitive transcranial magnetic stimulation","volume":"28","author":"Mayer","year":"2012","journal-title":"J. ECT"},{"key":"10.1016\/j.phrs.2024.107085_bib126","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib127","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107085_bib128","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","author":"Krystal","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib129","article-title":"Ketamine in neuropsychiatric disorders: an update","author":"Johnston","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib130","article-title":"No time to lose: the current state of research in rapid-acting psychotherapeutics","author":"Gordon","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.20230172","article-title":"Psychedelics as transformative therapeutics","volume":"180","author":"Roth","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib132","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.phrs.2024.107085_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112631","article-title":"Ketamine's dose related multiple mechanisms of actions: dissociative anesthetic to rapid antidepressant","volume":"390","author":"Lavender","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2024.107085_bib134","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/330604a0","article-title":"Synaptic plasticity. The role of NMDA receptors in learning and memory","volume":"330","author":"Collingridge","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107085_bib135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"History of anaesthesia: the ketamine story - past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.phrs.2024.107085_bib136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib137","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(88)90063-8","article-title":"Ketamine blocks an NMDA receptor-mediated component of synaptic transmission in rat hippocampus in a voltage-dependent manner","volume":"92","author":"Davies","year":"1988","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107085_bib138","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/09540261.2020.1854194","article-title":"Ketamine for depression","volume":"33","author":"Jelen","year":"2021","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib139","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib140","article-title":"Ethical considerations in rapid and novel treatments in psychiatry","author":"Haeusermann","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib141","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis","volume":"3","author":"Beck","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.phrs.2024.107085_bib142","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41380-022-01502-0","article-title":"Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia","volume":"27","author":"Abram","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib143","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/02698811221140011","article-title":"A unified model of ketamine's dissociative and psychedelic properties","volume":"37","author":"Marguilho","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib144","article-title":"NMDAR neurotransmission needed for persistent neuronal firing: potential roles in mental disorders","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cns.12081","article-title":"Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits","volume":"19","author":"Kocsis","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phrs.2024.107085_bib146","article-title":"Esketamine is approved in Europe for treating resistant major depressive disorder","volume":"367","author":"Mahase","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2024.107085_bib147","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ijnp\/pyab082","article-title":"Sex differences in the behavioral, molecular, and structural effects of ketamine treatment in depression","volume":"25","author":"Ponton","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib148","doi-asserted-by":"crossref","DOI":"10.1177\/10398562231211171","article-title":"What clinicians need to know about intranasal esketamine for treatment-resistant depression","author":"Hope","year":"2023","journal-title":"Austral Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114049","article-title":"Neurobiological, behavioral, and cognitive effects of ketamine in adolescents: a review of human and pre-clinical research","volume":"435","author":"Acevedo","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2024.107085_bib150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib151","doi-asserted-by":"crossref","DOI":"10.1177\/02698811231177240","article-title":"The safety of repeated ketamine dosing in paediatrics: a systematic review","author":"James","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib152","doi-asserted-by":"crossref","DOI":"10.1177\/02698811231171531","article-title":"Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth","author":"Chisamore","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib153","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/cap.2018.0030","article-title":"Intravenous Ketamine for adolescents with treatment-resistant depression: an open-label study","volume":"28","author":"Cullen","year":"2018","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib154","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2020.20010018","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial","volume":"178","author":"Dwyer","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib155","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaac.2017.01.006","article-title":"Ketamine as a treatment for adolescent depression: a case report","volume":"56","author":"Dwyer","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib156","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/cap.2019.0028","article-title":"Successful use of ketamine for the treatment of psychotic depression in a teenager","volume":"29","author":"Zarrinnegar","year":"2019","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib157","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-023-01432-w","article-title":"Ketamine use in child and adolescent psychiatry: emerging data in treatment-resistant depression, insights from adults, and future directions","author":"Ryan","year":"2023","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.phrs.2024.107085_bib158","doi-asserted-by":"crossref","first-page":"1118737","DOI":"10.3389\/fpsyt.2023.1118737","article-title":"Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression","volume":"14","author":"Skala","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib159","doi-asserted-by":"crossref","first-page":"1141988","DOI":"10.3389\/fpsyt.2023.1141988","article-title":"Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses","volume":"14","author":"Wolfson","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib160","article-title":"Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression","volume":"36","author":"Lan","year":"2023","journal-title":"Gen. Psychiatr."},{"key":"10.1016\/j.phrs.2024.107085_bib161","article-title":"Effect of repeated intravenous esketamine on adolescents with major depressive disorder and suicidal ideation: a randomized active-placebo-controlled trial","author":"Zhou","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib162","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1751-7893.2009.00131.x","article-title":"Paediatric major depressive disorder: neurobiology and implications for early intervention","volume":"3","author":"Cullen","year":"2009","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib163","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpsychires.2019.01.010","article-title":"Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression","volume":"110","author":"Freeman","year":"2019","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.phrs.2024.107085_bib164","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00737-021-01185-6","article-title":"Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials","volume":"25","author":"Jones","year":"2022","journal-title":"Arch. Women\u2019s. Ment. Health"},{"key":"10.1016\/j.phrs.2024.107085_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114579","article-title":"Sex differences in ketamine's therapeutic effects for mood disorders: a systematic review","volume":"312","author":"Benitah","year":"2022","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.phrs.2024.107085_bib166","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/clpt.2011.244","article-title":"Ketamine as a novel antidepressant: from synapse to behavior","volume":"91","author":"Murrough","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107085_bib167","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","article-title":"Sex differences in the antidepressant-like effects of ketamine","volume":"70","author":"Carrier","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib168","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.biopsych.2013.04.027","article-title":"Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats","volume":"74","author":"Parise","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib169","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-022-01994-y","article-title":"Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective","volume":"12","author":"Ledesma-Corvi","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib170","first-page":"9","article-title":"Sex differences in the antidepressant-like response of ketamine in adolescent rats: evaluating long-term safety through cognition. 11th IBRO World Congress of Neuroscience","author":"Jornet-Plaza","year":"2023","journal-title":"Granada Spain"},{"key":"10.1016\/j.phrs.2024.107085_bib171","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2021.05.002","article-title":"The resilient phenotype induced by prophylactic ketamine exposure during adolescence is mediated by the ventral tegmental area-nucleus accumbens pathway","volume":"90","author":"Parise","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib172","doi-asserted-by":"crossref","first-page":"5452727","DOI":"10.1155\/2019\/5452727","article-title":"\"Special K\" drug on adolescent rats: Oxidative damage and neurobehavioral impairments","volume":"2019","author":"de Carvalho Cart\u00e1genes","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2024.107085_bib173","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2015.01.008","article-title":"Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-na\u00efve and \"depressed\" mice exposed to chronic mild stress","volume":"290","author":"Franceschelli","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107085_bib174","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.biopsych.2015.12.025","article-title":"Sex Differences in effects of ketamine on behavior, spine density, and synaptic proteins in socially isolated rats","volume":"80","author":"Sarkar","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.581360","article-title":"Sex differences in the sustained effects of ketamine on resilience to chronic stress","volume":"14","author":"Okine","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2024.107085_bib176","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ynstr.2018.09.001","article-title":"On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods","volume":"9","author":"Strong","year":"2018","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.phrs.2024.107085_bib177","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215554","article-title":"Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test","volume":"14","author":"Fitzgerald","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107085_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136301","article-title":"Sex-specific effects of social isolation stress and ketamine on hippocampal plasticity","volume":"766","author":"Logue","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2024.107085_bib179","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.659052","article-title":"Repeated dosing of ketamine in the forced swim test: are multiple shots better than one","volume":"12","author":"Weston","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111928","article-title":"Long-lasting effects of repeated ketamine administration in adult and adolescent rats","volume":"369","author":"Bates","year":"2019","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.phrs.2024.107085_bib182","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107085_bib183","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jnc.15536","article-title":"Molecular targets of psychedelic-induced plasticity","volume":"162","author":"Jaster","year":"2022","journal-title":"J. Neurochem"},{"key":"10.1016\/j.phrs.2024.107085_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106837","article-title":"Molecular mechanisms of rapid-acting antidepressants: new perspectives for developing antidepressants","volume":"194","author":"Chen","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2024.107085_bib185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107085_bib186","doi-asserted-by":"crossref","first-page":"1076459","DOI":"10.3389\/fpsyt.2022.1076459","article-title":"Serotonergic psychedelics for depression: what do we know about neurobiological mechanisms of action","volume":"13","author":"Husain","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib187","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/cpt.2487","article-title":"Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects","volume":"111","author":"Becker","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2024.107085_bib188","first-page":"105","article-title":"Cannabis: drug of abuse and therapeutic agent, two sides of the same coin","volume":"75","author":"Canseco-Alba","year":"2023","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.phrs.2024.107085_bib189","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and bads of endocannabinoid system as a therapeutic target: Lessons learned after 30 years","author":"Maccarrone","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2024.107085_bib190","unstructured":"V. Preedy, V. Patel, C. Martin, eds., Medicinal usage of Cannabis and Cannabinoids, Academic Press, Cambridge, Massachusetts. (2023). ISBN 9780323915786."},{"key":"10.1016\/j.phrs.2024.107085_bib191","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2018.09.058","article-title":"Cannabinoids in depressive disorders","volume":"213","author":"Poleszak","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.636228","article-title":"Exo- and endo-cannabinoids in depressive and suicidal behaviors","volume":"12","author":"Mannekote Thippaiah","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib193","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuron.2022.12.022","article-title":"THC and CBD: similarities and differences between siblings","volume":"111","author":"Stella","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2024.107085_bib194","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: a potential new alternative for the treatment of anxiety, depression, and psychotic disorders","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2024.107085_bib195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40211-020-00334-0","article-title":"Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression","volume":"35","author":"Laczkovics","year":"2021","journal-title":"Neuropsychiatr"},{"key":"10.1016\/j.phrs.2024.107085_bib196","doi-asserted-by":"crossref","first-page":"21m14130","DOI":"10.4088\/JCP.21m14130","article-title":"Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial","volume":"83","author":"Berger","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib197","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.phrs.2024.107085_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110508","article-title":"Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol","volume":"115","author":"Mart\u00edn-S\u00e1nchez","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib199","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ph14121269","article-title":"Strain, sex-, and time-dependent antidepressant-like effects of cannabidiol","volume":"14","author":"Silote","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.phrs.2024.107085_bib200","first-page":"9","article-title":"Sex- and dose-dependent antidepressant-like effects of cannabidiol in adult rats: lack of hippocampal neurogenesis regulation. 11th IBRO World Congress of Neuroscience","author":"G\u00e1lvez-Melero","year":"2023","journal-title":"Granada Spain"},{"key":"10.1016\/j.phrs.2024.107085_bib201","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s43440-021-00285-5","article-title":"Antidepressant-like effects of cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure","volume":"73","author":"Bis-Humbert","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2024.107085_bib202","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fphar.2017.00269","article-title":"Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders","volume":"8","author":"Campos","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchemneu.2019.04.006","article-title":"Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms","volume":"98","author":"Silote","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.phrs.2024.107085_bib204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42238-023-00186-9","article-title":"The therapeutic potential of purified cannabidiol","volume":"5","author":"O'Sullivan","year":"2023","journal-title":"J. Cannabis Res"},{"key":"10.1016\/j.phrs.2024.107085_bib205","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11095-023-03469-1","article-title":"Cannabidiol for the treatment of brain disorders: therapeutic potential and routes of administration","volume":"40","author":"Yau","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2024.107085_bib206","series-title":"Medicinal Usage of Cannabis and Cannabinoids","first-page":"217","article-title":"Cannabidiol in medicinal usage of stress: modeling investigations into cocaine","author":"Valverde","year":"2023"},{"key":"10.1016\/j.phrs.2024.107085_bib207","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/ijms22041863","article-title":"Cannabidiol as a potential treatment for anxiety and mood disorders: Molecular targets and epigenetic insights from preclinical research","volume":"22","author":"Melas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib208","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/can.2018.0006","article-title":"A cross-sectional study of cannabidiol users","volume":"3","author":"Corroon","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.phrs.2024.107085_bib209","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42238-021-00061-5","article-title":"Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems","volume":"3","author":"Moltke","year":"2021","journal-title":"J. Cannabis Res"},{"key":"10.1016\/j.phrs.2024.107085_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.837946","article-title":"Cannabidiol (CBD) in the self-treatment of depression-exploratory study and a new phenomenon of concern for psychiatrists","volume":"13","author":"Wieckiewicz","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107085_bib211","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10787-022-01020-z","article-title":"Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions","volume":"30","author":"Henson","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib212","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/npr2.12183","article-title":"An initial analysis of the UK Medical Cannabis Registry: outcomes analysis of first 129 patients","volume":"41","author":"Erridge","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.phrs.2024.107085_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2021.101476","article-title":"Medical cannabis and cannabis-based medicine show both potential efficacy and potential harms: cross-sectional comparison with controls on self-rated and interviewer-rated outcomes within the Danish pilot program on medical cannabis","volume":"45","author":"Kudahl","year":"2021","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.phrs.2024.107085_bib214","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272241","article-title":"A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years","volume":"17","author":"Vickery","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107085_bib215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14737175.2022.2161894","article-title":"Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry","volume":"22","author":"Mangoo","year":"2022","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.phrs.2024.107085_bib216","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/can.2017.0034","article-title":"Chronic adolescent \u03949-tetrahydrocannabinol treatment of male mice leads to long-term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment","volume":"2","author":"Murphy","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.phrs.2024.107085_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.711639","article-title":"Cannabidiol exposure during the mouse adolescent period is without harmful behavioral effects on locomotor activity, anxiety, and spatial memory","volume":"15","author":"Kaplan","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2024.107085_bib218","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00213-021-05769-z","article-title":"Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence","volume":"238","author":"Murillo-Rodr\u00edguez","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib219","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.3390\/ijms22168899","article-title":"Long-term consequences of adolescent exposure to THC-rich\/CBD-poor and CBD-rich\/THC-poor Combinations: a comparison with pure THC treatment in female rats","volume":"22","author":"Gabaglio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib220","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2024.107085_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.133012","article-title":"Cannabis: chemistry, extraction and therapeutic applications","volume":"289","author":"Pattnaik","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.phrs.2024.107085_bib222","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"de Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2024.107085_bib223","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1056\/NEJMoa2302399","article-title":"Ketamine versus ECT for nonpsychotic treatment-resistant major depression","volume":"388","author":"Anand","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2024.107085_bib224","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S1092852922000773","article-title":"Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities","volume":"28","author":"Rocha","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.phrs.2024.107085_bib225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.focus.20220076","article-title":"Pharmacologic approaches to suicide prevention","volume":"21","author":"Zisook","year":"2023","journal-title":"Focus"},{"key":"10.1016\/j.phrs.2024.107085_bib226","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib227","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107085_bib228","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2024.107085_bib229","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107085_bib230","article-title":"Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine","volume":"224","author":"Deyama","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib231","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2024.107085_bib232","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00213-023-06410-x","article-title":"Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling - a potential therapeutic concept?","volume":"240","author":"Madjid","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2024.107085_bib233","doi-asserted-by":"crossref","first-page":"1275783","DOI":"10.3389\/fnmol.2023.1275783","article-title":"Electroconvulsive seizures regulate various stages of hippocampal cell genesis and mBDNF at different times after treatment in adolescent and adult rats of both sexes","volume":"16","author":"Ledesma-Corvi","year":"2023","journal-title":"Front. Mol. Neurosci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182400029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182400029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:49:38Z","timestamp":1760914178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182400029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":233,"alternative-id":["S104366182400029X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107085","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel rapid treatment options for adolescent depression","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107085"}}